Distinct hematopoietic progenitor compartments are delineated by the expression of aldehyde dehydrogenase and CD34.

A broad range of hematopoietic stem cells and progenitors reside within a fraction of umbilical cord blood (UCB) that exhibits low light scatter properties (SSC(lo)) and high expression of aldehyde dehydrogenase (ALDH(br)). Many SSC(lo) ALDH(br) cells coexpress CD34; however, other cells express either ALDH or CD34. To investigate the developmental potential of these cell subsets, purified ALDH(br) CD34+, ALDH(neg) CD34+, and ALDH(br) CD34(neg) UCB cells were characterized within a variety of in vivo and in vitro assays. Primitive progenitors capable of multilineage development were monitored in long- and short-term repopulation assays performed on nonobese diabetic/severe combined immunodeficiency (NOD/SCID) mice, and in primary and secondary long-term culture assays. These progenitors were highly enriched within the ALDH(br) CD34+ fraction. This cell fraction also enriched short-term myeloid progenitors that were detected in vitro. By comparison, ALDH(neg) CD34+ cells contained few primitive progenitors and had diminished short-term myeloid potential but exhibited enhanced short-term natural killer (NK) cell development in vitro. The ALDH(br) CD34(neg) cells were not efficiently supported by any of the assays used. These studies suggested that in particular the expression of ALDH delineated distinct CD34+ stem cell and progenitor compartments. The differential expression of ALDH may provide a means to explore normal and malignant processes associated with myeloid and lymphoid development.

[1]  J. Nolta,et al.  Isolation of Human CD34- Cells with High Aldehyde Dehydrogenase Activity Reveals a Novel Population with Hematopoietic Repopulating Potential. , 2004 .

[2]  M. Gobbi,et al.  Efficacy and toxicity of FLAI vs ICE for induction treatment of newly diagnosed AML patients, younger than 60 years , 2004 .

[3]  J. Nolta,et al.  Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity. , 2004, Blood.

[4]  Mahendra S Rao,et al.  In search of "stemness". , 2004, Experimental hematology.

[5]  A. Balber,et al.  Mobilized peripheral blood SSCloALDHbr cells have the phenotypic and functional properties of primitive haematopoietic cells and their number correlates with engraftment following autologous transplantation , 2003, British journal of haematology.

[6]  N. Hogg,et al.  Rapid recruitment of inflammatory monocytes is independent of neutrophil migration. , 2003, Blood.

[7]  M. Ogawa,et al.  Reversible expression of CD34 by adult human bone marrow long-term engrafting hematopoietic stem cells. , 2003, Experimental hematology.

[8]  S. Ikehara,et al.  SCID-repopulating cell activity of human cord blood-derived CD34- cells assured by intra-bone marrow injection. , 2003, Blood.

[9]  O. Colvin,et al.  32 Aldehyde dehydrogenase is expressed by primitive CD34+ hematopoietic progenitors , 2003 .

[10]  J. Nolta,et al.  Reversibility of CD34 expression on human hematopoietic stem cells that retain the capacity for secondary reconstitution. , 2003, Blood.

[11]  M. Fackler,et al.  Human CD34+ cell preparations contain over 100-fold greater NOD/SCID mouse engrafting capacity than do CD34- cell preparations. , 2001, Experimental hematology.

[12]  L. Barsky,et al.  Identification of a novel, human multilymphoid progenitor in cord blood. , 2001, Blood.

[13]  I. Weissman,et al.  A clonogenic common myeloid progenitor that gives rise to all myeloid lineages , 2000, Nature.

[14]  Hoechst dye efflux reveals a novel CD7(+)CD34(-) lymphoid progenitor in human umbilical cord blood. , 2000, Blood.

[15]  M. Goodell.  CD34+ or CD34−: Does it Really Matter? , 1999 .

[16]  O. Colvin,et al.  Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[17]  K. Moore,et al.  The myeloid-lymphoid initiating cell (ML-IC) assay assesses the fate of multipotent human progenitors in vitro. , 1999, Blood.

[18]  K. Moore,et al.  The type of stromal feeder used in limiting dilution assays influences frequency and maintenance assessment of human long-term culture initiating cells , 1999, Leukemia.

[19]  K. Moore,et al.  Single adult human CD34(+)/Lin-/CD38(-) progenitors give rise to natural killer cells, B-lineage cells, dendritic cells, and myeloid cells. , 1999, Blood.

[20]  J. Dick,et al.  A newly discovered class of human hematopoietic cells with SCID-repopulating activity , 1998, Nature Medicine.

[21]  I. Weissman,et al.  Identification of Clonogenic Common Lymphoid Progenitors in Mouse Bone Marrow , 1997, Cell.

[22]  K. Moore,et al.  In vitro maintenance of highly purified, transplantable hematopoietic stem cells. , 1997, Blood.

[23]  J. Dick,et al.  Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[24]  David A. Williams,et al.  Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy , 1996, Nature Medicine.

[25]  C. Civin,et al.  Sustained, retransplantable, multilineage engraftment of highly purified adult human bone marrow stem cells in vivo. , 1996, Blood.

[26]  R. Storb,et al.  Transplantation of allogeneic CD34+ peripheral blood stem cells in patients with advanced hematologic malignancy. , 1996, Blood.

[27]  C. Civin,et al.  Highly purified CD34-positive cells reconstitute hematopoiesis. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  M. Fackler,et al.  Characterization of mouse lymphohematopoietic stem cells lacking spleen colony-forming activity. , 1996, Blood.

[29]  Richard J. Jones,et al.  Assessment of aldehyde dehydrogenase in viable cells. , 1995, Blood.

[30]  J. Miller,et al.  Differentiation of natural killer (NK) cells from human primitive marrow progenitors in a stroma-based long-term culture system: identification of a CD34+7+ NK progenitor. , 1994, Blood.

[31]  J. Cupp,et al.  Expression of CD33, CD38, and HLA-DR on CD34+ human fetal liver progenitors with a high proliferative potential. , 1994, Blood.

[32]  Lemischka Ir.  Clonal, in vivo behavior of the totipotent hematopoietic stem cell. , 1991 .

[33]  I. Lemischka.  Clonal, in vivo behavior of the totipotent hematopoietic stem cell. , 1991, Seminars in immunology.

[34]  I. Lemischka,et al.  Clonal and systemic analysis of long-term hematopoiesis in the mouse. , 1990, Genes & development.

[35]  J. Russo,et al.  Inhibition of mouse cytosolic aldehyde dehydrogenase by 4-(diethylamino)benzaldehyde. , 1988, Biochemical pharmacology.